Alan J Thompson

Developing clinical outcome measures in multiple sclerosis: an evolving process
Mult Scler 2002 8: 357-358. [PDF] [References] [Request Permission]  

R A Rudick, G Cutter, and S Reingold

The Multiple Sclerosis Functional Composite: a new clinical outcome measure for multiple sclerosis trials
Mult Scler 2002 8: 359-365. [Abstract] [PDF] [References] [Request Permission]  

B MJ Uitdehaag, H J Adèr, T JA Roosma, V de Groot, N F Kalkers, and C H Polman

Multiple sclerosis functional composite: impact of reference population and interpretation of changes
Mult Scler 2002 8: 366-371. [Abstract] [PDF] [References] [Request Permission]  

C R Nicholl, N B Lincoln, and E D Playford

The reliability and validity of the Nottingham Extended Activities of Daily Living Scale in patients with multiple sclerosis
Mult Scler 2002 8: 372-376. [Abstract] [PDF] [References] [Request Permission]  

P Vermersch, J de Seze, B Delisse, S Lemaire, and T Stojkovic

Quality of life in multiple sclerosis: influence of interferon-ß1a (Avonex®) treatment
Mult Scler 2002 8: 377-381. [Abstract] [PDF] [References] [Request Permission]  

R L Aupperle, W W Beatty, F deNAP Shelton, and S T Gontkovsky

Three screening batteries to detect cognitive impairment in multiple sclerosis
Mult Scler 2002 8: 382-389. [Abstract] [PDF] [References] [Request Permission]  

E M Martínez-Cáceres, C Espejo, L Brieva, I Pericot, M Tintoré, I Sáez-Torres, and X Montalban

Expression of chemokine receptors in the different clinical forms of multiple sclerosis
Mult Scler 2002 8: 390-395. [Abstract] [PDF] [References] [Request Permission]  

V Özenci, M Kouwenhoven, and H Link

Cytokines in multiple sclerosis: methodological aspects and pathogenic implications
Mult Scler 2002 8: 396-404. [Abstract] [PDF] [References] [Request Permission]  

CHAMPS Study Group

Predictors of short-term disease activity following a first clinical demyelinating event: analysis of the CHAMPS placebo groupy
Mult Scler 2002 8: 405-409. [Abstract] [PDF] [References] [Request Permission]  

N F Kalkers, H Vrenken, B MJ Uitdehaag, C H Polman, and F Barkhof

Brain atrophy in multiple sclerosis: impact of lesions and of damage of whole brain tissue
Mult Scler 2002 8: 410-414. [Abstract] [PDF] [References] [Request Permission]  

E LJ Hoogervorst, C H Polman, and F Barkhof

Cerebral volume changes in multiple sclerosis patients treated with high-dose intravenous methylprednisolone
Mult Scler 2002 8: 415-419. [Abstract] [PDF] [References] [Request Permission]  

R Leigh, J Ostuni, D Pham, A Goldszal, B K Lewis, T Howard, N Richert, H McFarland, and J A Frank

Estimating cerebral atrophy in multiple sclerosis patients from various MR pulse sequences
Mult Scler 2002 8: 420-429. [Abstract] [PDF] [References] [Request Permission]  

S O'Riordan, A M Nor, and M Hutchinson

CADASIL imitating multiple sclerosis: the importance of MRI markers
Mult Scler 2002 8: 430-432. [Abstract] [PDF] [References] [Request Permission]  

S J Hickman, G J Barker, P D Molyneux, and D H Miller

Technical note: the comparison of hypointense lesions from ‘pseudo-T1’ and T1-weighted images in secondary progressive multiple sclerosis
Mult Scler 2002 8: 433-435. [Abstract] [PDF] [References] [Request Permission]  

Q Hao, N Miyashita, M Matsui, H-Y Wang, T Matsushima, and T Saida

Chlamydia pneumoniae infection associated with enhanced MRI spinal lesions in multiple sclerosis
Mult Scler 2002 8: 436-440. [Abstract] [PDF] [References] [Request Permission]  

R G Ghalie, E Mauch, G Edan, H P Hartung, R E Gonsette, S Eisenmann, E Le Page, M D Butine, and D E Goodkin

A study of therapy-related acute leukaemia after mitoxantrone therapy for multiple sclerosis
Mult Scler 2002 8: 441-445. [Abstract] [PDF] [References] [Request Permission]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.